Structure-based computational database screening, in vitro assay, and NMR assessment of compounds that target TAR RNA

Chemistry and Biology

Volumn 9, Issue 2, 2002, Pages 185-193

  Lind, Kenneth E ^a   Du, Zhihua ^a   Fujinaga, Koh ^a   Peterlin, B Matija ^a,b   James, Thomas L ^a  

^a Department of Pharmaceutical Chemistry ^*  (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; LIGAND; RNA BINDING PROTEIN; TRANSACTIVATOR PROTEIN; VIRUS RNA;

ARTICLE; BINDING SITE; CHEMISTRY; COMPUTER SIMULATION; DRUG ANTAGONISM; DRUG DESIGN; DRUG EFFECT; GENETICS; HELA CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; LONG TERMINAL REPEAT; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHYSIOLOGY; PROTEIN BINDING; STRUCTURE ACTIVITY RELATION; TRANSACTIVATION; VIRUS REPLICATION;

ANTI-HIV AGENTS; BINDING SITES; COMPUTER SIMULATION; DRUG DESIGN; GENE PRODUCTS, TAT; HELA CELLS; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; LIGANDS; MAGNETIC RESONANCE SPECTROSCOPY; PROTEIN BINDING; RNA, VIRAL; RNA-BINDING PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP; TRANS-ACTIVATION (GENETICS); VIRUS REPLICATION;

EID: 0036008846     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-5521(02)00106-0     Document Type: Article

References (52)

1. Modulation of RNA function by aminoglycoside antibiotics
2. Structure-based discovery of ligands targeted to the RNA double helix
3. Docking of cationic antibiotics to negatively charged pockets in RNA folds
4. Recent successes and continuing limitations in computer-aided drug design
5. Identification of ligands for RNA targets via structure-based virtual screening: HIV-1 TAR
6. Three-dimensional RNA structure-based drug discovery
7. Interactions between Tat and TAR and human immunodeficiency virus replication are facilitated by human cyclin T1 but not cyclins T2a or T2b
8. Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product
9. Mutational analysis of the conserved basic domain of human immunodeficiency virus tat protein
10. Conserved nucleotides in the TAR RNA sStem of human immunodeficiency virus type 1 are critical for Tat binding and trans activation: Model for TAR RNA tertiary structure
11. Inhibition of HIV replication in acute and chronic infections in vitro by a Tat antagonist
12. Inhibitors of protein-RNA complexation that target the RNA: Specific recognition of human immunodeficiency virus type 1 TAR RNA by small organic molecules
13. Analysis of trans-acting response decoy RNA-mediated inhibition of human immunodeficiency virus type-1 transactivation
14. A new class of HIV-1 Tat antagonist acting through Tat-TAR inhibition
15. Small molecules that selectively block RNA binding of HIV-1 Rev protein inhibit Rev function and viral production
16. Aminoglycoside-arginine conjugates that bind TAR RNA: Synthesis, characterization, and antiviral activity
17. Critical evaluation of search algorithms for automated molecular docking and database screening
18. ICM - A new method for protein modeling and design - Applications to docking and structure prediction from the distorted native conformation
19. Structure-based design of ligands for protein basic domains: Application to the HIV-1 Tat protein
20. Biochemistry - Adaptive recognition by nucleic acid aptamers
21. Structure, recognition and adaptive binding in RNA aptamer complexes
22. Solution structure of an ATP-binding RNA aptamer reveals a novel fold
23. Structural basis of ligand discrimination by two related RNA aptamers resolved by NMR spectroscopy
24. The 1.3 angstrom crystal structure of a biotin-binding pseudoknot and the basis for RNA molecular recognition
25. Molecular recognition in the FMN-RNA aptamer complex
26. Structural origins of gentamicin antibiotic action
27. Structural basis for recognition of the RNA major groove in the tau exon 10 splicing regulatory element by aminoglycoside antibiotics
28. Saccharide-RNA recognition in an aminoglycoside antibiotic-RNA aptamer complex
29. Structural rearrangements of HIV-1 Tat-responsive RNA upon binding of neomycin B
30. Structure of the A site of Escherichia coli 16S ribosomal RNA complexed with an aminoglycoside antibiotic
31. Interlocking structural motifs mediate molecular discrimination by a theophylline-binding RNA
32. Solution structure of the tobramycin-RNA aptamer complex
33. Saccharide-RNA recognition in a complex formed between neomycin B and an RNA aptamer
34. An RNA motif that binds ATP
35. Molecular recognition of amino acids by RNA-aptamers - An L-citrulline binding RNA motif and its evolution into an L-arginine binder
36. Functional requirements for specific ligand recognition by a biotin-binding RNA pseudoknot
37. Isolation of RNA aptamers for biological cofactors by in vitro selection
38. A novel RNA motif for neomycin recognition
39. Binding of neomycin to the TAR element of HIV-1 RNA induces dissociation of Tat protein by an allosteric mechanism
40. RNA sequence determinants for aminoglycoside binding to an a-site rRNA model oligonucleotide
41. High-resolution molecular discrimination by RNA
42. Specific binding of aminoglycoside antibiotics to RNA
43. Analytical Debye-Hückel model for electrostatic potentials around dissolved DNA
44. Drug-like properties and the causes of poor solubility and poor permeability
45. Activity of phenothiazines against antibiotic resistant Mycobacterium tuberculosis: A review supporting further studies that may elucidate the potential use of thioridazine as anti-tuberculosis therapy
46. Conformation of the TAR RNA-arginine complex by NMR spectroscopy
47. Solution structure of the HIV-2 TAR-argininamide complex
48. Conformational analysis of flexible ligands in macromolecular receptor sites
49. Synthesis of small RNAs using T7 RNA polymerase
50. NMRPipe: A multidimensional spectral processing system based on UNIX pipes
51. Quadrature fourier NMR detection: Simplex multiplex for dual detection and discussion